Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00278161 · OUTCOME

Engraftment

Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma · Source last updated 2018-11-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
days
Interval / dispersion
Full Range
Time frame
Up to 43 days

What was measured

Median days to neutrophil and platelet recovery. Neutrophil recovery is defined as absolute neutrophil count \>= 500 cells per microliter; platelet recovery is defined as untransfused platelet count \>= 20 \* 10\^9 cells per liter.

Groups in this outcome

R-HiCy

Rituximab (R) and high-dose cyclophosphamide (HiCy) with pegfilgrastim support. Pegfilgrastim: 6 mg SQ 24-48 hours after last dose of cyclophosphamide. Rituximab: 375 mg/m\^2/day on Days 1, 4, 8, 11, 45, and 52. Cyclophosphamide: 50 mg/kg/day on Days 15, 16, 17, and 18.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
R-HiCy81

Reported measurements

Neutrophil
Values in days · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
R-HiCy15Not reported1132Not reported
Platelet
Values in days · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
R-HiCy15Not reported043Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        11
        upper Limit
        32
        value
        15
    title
    Neutrophil
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        43
        value
        15
    title
    Platelet
denoms
  1. counts
    1. group Id
      OG000
      value
      81
    units
    Participants
description
Median days to neutrophil and platelet recovery. Neutrophil recovery is defined as absolute neutrophil count \>= 500 cells per microliter; platelet recovery is defined as untransfused platelet count \>= 20 \* 10\^9 cells per liter.
dispersion Type
Full Range
groups
  1. description
    Rituximab (R) and high-dose cyclophosphamide (HiCy) with pegfilgrastim support. Pegfilgrastim: 6 mg SQ 24-48 hours after last dose of cyclophosphamide. Rituximab: 375 mg/m\^2/day on Days 1, 4, 8, 11, 45, and 52. Cyclophosphamide: 50 mg/kg/day on Days 15, 16, 17, and 18.
    id
    OG000
    title
    R-HiCy
param Type
MEDIAN
reporting Status
POSTED
time Frame
Up to 43 days
title
Engraftment
type
PRIMARY
unit Of Measure
days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice